semaglutide and colitis Colonic Ischemia Following Use: A Case Report | SN Comprehensive Clinical Medicine Semaglutide and Ulcerative Colitis: Safety

Key Findings: Most common: Nausea (43%), diarrhea (33%), vomiting (21%) Unique to retatrutide: Dysesthesia (20.9% @ 12mg in TRIUMPH-4, 8.8% @ 9mg) Discontinuation rate: 18.2% in TRIUMPH-4, 11.3% in TRIUMPH-1 (general obesity population) compared to semaglutide 6.9%, tirzepatide 6.2% Good news: Most side effects peak during dose escalation and improve significantly after week 16 Management: Slow titration, dietary modifications, and proper timing dramatically reduce severity Understanding the Three Categories of Side Effects 1

It may also help increase focus and concentration, improve mood, and reduce anxiety

Manufactured in Compliance with Good Manufacturing Practices (GMP) Pure Tides Therapy follows Good Manufacturing Practices (GMP) to ensure high quality and safety

These proven GLP-1 medications help patients with a BMI of 30+ , or 27+ with weight-related conditions , achieve real and lasting results all from the comfort of home